AI-generated summary
The authors ran a double-blind, placebo-controlled crossover trial of bright light therapy combined with either melatonin or placebo in dementia patients with motor restlessness. They report that light combined with placebo was associated with less restlessness and more cooperation, while adding melatonin showed no additional benefit and some patients became more aggressive. The study included only six patients who completed the trial.
- Participants
- 6
- Who or what was studied
- Patients with dementia (DSM-IV) and motor restless behaviour on a psychogeriatric ward, with six completing the trial
- Limits stated in the abstract
- Very small sample of six patients who completed the trial, with the abstract reporting no statistical results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Dementia, Placebo-controlled, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.